Lewis T Williams Insider Trading $FPRX FIVE PRIME THERAPEUTICS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Lewis T Williams.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Lewis T Williams. Lewis T Williams is Director in BECKMAN COULTER INC ($BEC) and Director in FIVE PRIME THERAPEUTICS INC ($FPRX) and Executive Chairman in FIVE PRIME THERAPEUTICS INC ($FPRX) and President and CEO in FIVE PRIME THERAPEUTICS INC ($FPRX) and President, CEO and Chairman in FIVE PRIME THERAPEUTICS INC ($FPRX) and Director in Protagonist Therapeutics, Inc ($PTGX) and Director in Neoleukin Therapeutics, Inc. ($AQXP).
Lewis T Williams in FIVE PRIME THERAPEUTICS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Lewis T Williams: Director, Executive Chairman, President, CEO and Chairman, President and CEO
Holdings: 455,336 shares
Current Value: $20,663,148
Latest Transaction: Sep 04 2019
$FPRX Market Capitalization: $1.23B
$FPRX Previous Close: $45.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Lewis T Williams in FIVE PRIME THERAPEUTICS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BEC, FPRX, NLTX, PTGX
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Sep 04 2019 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | Director | Payment of Exercise | F | 5.43 | 7,024 | 38,140 | 455,336 | 462.4 K to 455.3 K (-1.52 %) |
| Jun 12 2019 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | Director | Option Exercise | A | 6.09 | 15,000 | 91,350 | 15,000 | |
| Feb 27 2019 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | Director | Payment of Exercise | F | 11.95 | 926 | 11,066 | 461,360 | 462.3 K to 461.4 K (-0.20 %) |
| Feb 07 2019 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | Director | Payment of Exercise | F | 11.43 | 3,144 | 35,936 | 462,286 | 465.4 K to 462.3 K (-0.68 %) |
| Nov 13 2018 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | Executive Chairman | Option Exercise | M | 4.56 | 91,217 | 415,950 | 0 | |
| Nov 13 2018 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | Executive Chairman | Buy | M | 4.56 | 91,217 | 415,950 | 465,430 | 374.2 K to 465.4 K (+24.38 %) |
| Sep 05 2018 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | Executive Chairman | Payment of Exercise | F | 14.00 | 7,024 | 98,336 | 374,213 | 381.2 K to 374.2 K (-1.84 %) |
| Feb 28 2018 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | Executive Chairman | Option Exercise | A | 18.69 | 30,000 | 560,700 | 30,000 | |
| Feb 28 2018 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | Executive Chairman | Grant | A | 0.00 | 5,000 | 0 | 381,237 | 376.2 K to 381.2 K (+1.33 %) |
| Feb 07 2018 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | Executive Chairman | Payment of Exercise | F | 18.42 | 3,137 | 57,784 | 376,237 | 379.4 K to 376.2 K (-0.83 %) |
| Sep 06 2017 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Payment of Exercise | F | 34.34 | 7,827 | 268,779 | 381,958 | 389.8 K to 382 K (-2.01 %) |
| Mar 03 2017 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Payment of Exercise | F | 44.77 | 34,532 | 1,545,998 | 388,754 | 423.3 K to 388.8 K (-8.16 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | A | 45.38 | 101,250 | 4,594,725 | 101,250 | |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Grant | A | 0.00 | 16,875 | 0 | 423,286 | 406.4 K to 423.3 K (+4.15 %) |
| Feb 09 2017 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Gift | G | 0.00 | 22,416 | 0 | 406,411 | 428.8 K to 406.4 K (-5.23 %) |
| Jan 05 2017 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Payment of Exercise | F | 48.60 | 5,065 | 246,159 | 428,827 | 433.9 K to 428.8 K (-1.17 %) |
| Dec 23 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 5.54 | 29,816 | 165,181 | 31,159 | |
| Dec 23 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 8.49 | 10 | 85 | 16,349 | |
| Dec 23 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 6.89 | 19 | 131 | 14,438 | |
| Dec 23 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 4.56 | 155 | 707 | 91,217 | |
| Dec 23 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Sell | S | 51.02 | 300 | 15,306 | 433,892 | 434.2 K to 433.9 K (-0.07 %) |
| Dec 23 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Sell | S | 50.49 | 29,700 | 1,499,553 | 434,192 | 463.9 K to 434.2 K (-6.40 %) |
| Dec 23 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 5.54 | 29,816 | 165,181 | 463,892 | 434.1 K to 463.9 K (+6.87 %) |
| Dec 23 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 8.49 | 10 | 85 | 434,076 | 434.1 K to 434.1 K (0.00 %) |
| Dec 23 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 6.89 | 19 | 131 | 434,066 | 434 K to 434.1 K (0.00 %) |
| Dec 23 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 4.56 | 155 | 707 | 434,047 | 433.9 K to 434 K (+0.04 %) |
| Sep 15 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Gift | G | 0.00 | 407 | 0 | 433,892 | 434.3 K to 433.9 K (-0.09 %) |
| Sep 01 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Gift | G | 44.74 | 22,416 | 1,002,892 | 434,299 | 456.7 K to 434.3 K (-4.91 %) |
| Sep 01 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Payment of Exercise | F | 44.74 | 7,613 | 340,606 | 456,715 | 464.3 K to 456.7 K (-1.64 %) |
| Aug 29 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | A | 43.71 | 180,000 | 7,867,800 | 180,000 | |
| Aug 29 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Grant | A | 0.00 | 42,500 | 0 | 464,328 | 421.8 K to 464.3 K (+10.08 %) |
| May 13 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 1.23 | 81,300 | 99,999 | 0 | |
| May 13 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 1.23 | 81,300 | 99,999 | 421,828 | 340.5 K to 421.8 K (+23.87 %) |
| Apr 07 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 8.49 | 26,852 | 227,973 | 69,150 | |
| Apr 07 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 8.49 | 25,949 | 220,307 | 96,002 | |
| Apr 07 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Sell | S | 43.17 | 26,852 | 1,159,201 | 340,528 | 367.4 K to 340.5 K (-7.31 %) |
| Apr 07 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 8.49 | 26,852 | 227,973 | 367,380 | 340.5 K to 367.4 K (+7.89 %) |
| Apr 07 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Sell | S | 43.00 | 25,949 | 1,115,807 | 340,528 | 366.5 K to 340.5 K (-7.08 %) |
| Apr 07 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 8.49 | 25,949 | 220,307 | 366,477 | 340.5 K to 366.5 K (+7.62 %) |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 6.89 | 14,044 | 96,763 | 14,457 | |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 6.89 | 9,215 | 63,491 | 28,501 | |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Sell | S | 40.02 | 14,044 | 562,041 | 340,528 | 354.6 K to 340.5 K (-3.96 %) |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 6.89 | 14,044 | 96,763 | 354,572 | 340.5 K to 354.6 K (+4.12 %) |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Sell | S | 40.01 | 9,215 | 368,692 | 340,528 | 349.7 K to 340.5 K (-2.63 %) |
| Mar 31 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 6.89 | 9,215 | 63,491 | 349,743 | 340.5 K to 349.7 K (+2.71 %) |
| Mar 03 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Option Exercise | M | 6.89 | 23,259 | 160,255 | 37,716 | |
| Mar 03 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 36.01 | 23,259 | 837,557 | 340,352 | 363.6 K to 340.4 K (-6.40 %) |
| Mar 03 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Buy | M | 6.89 | 23,259 | 160,255 | 363,611 | 340.4 K to 363.6 K (+6.83 %) |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Option Exercise | M | 4.56 | 35,614 | 162,400 | 91,372 | |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Option Exercise | M | 4.56 | 35,615 | 162,404 | 126,986 | |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 35.48 | 121 | 4,293 | 340,352 | 340.5 K to 340.4 K (-0.04 %) |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 34.70 | 4,528 | 157,122 | 340,473 | 345 K to 340.5 K (-1.31 %) |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 33.76 | 12,408 | 418,894 | 345,001 | 357.4 K to 345 K (-3.47 %) |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 32.74 | 18,557 | 607,556 | 357,409 | 376 K to 357.4 K (-4.94 %) |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Buy | M | 4.56 | 35,614 | 162,400 | 375,966 | 340.4 K to 376 K (+10.46 %) |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 34.84 | 3,729 | 129,918 | 340,352 | 344.1 K to 340.4 K (-1.08 %) |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 33.83 | 11,800 | 399,194 | 344,081 | 355.9 K to 344.1 K (-3.32 %) |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 32.79 | 20,086 | 658,620 | 355,881 | 376 K to 355.9 K (-5.34 %) |
| Feb 08 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Buy | M | 4.56 | 35,615 | 162,404 | 375,967 | 340.4 K to 376 K (+10.46 %) |
| Apr 22 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 8.49 | 48,121 | 408,547 | 16,349 | |
| Apr 22 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 8.49 | 550 | 4,670 | 64,470 | |
| Apr 22 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Sell | S | 48.05 | 48,121 | 2,312,214 | 340,528 | 388.6 K to 340.5 K (-12.38 %) |
| Apr 22 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 8.49 | 48,121 | 408,547 | 388,649 | 340.5 K to 388.6 K (+14.13 %) |
| Apr 22 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Sell | S | 48.00 | 550 | 26,400 | 340,528 | 341.1 K to 340.5 K (-0.16 %) |
| Apr 22 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 8.49 | 550 | 4,670 | 341,078 | 340.5 K to 341.1 K (+0.16 %) |
| Apr 18 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 8.49 | 1,405 | 11,928 | 65,020 | |
| Apr 18 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Sell | S | 48.00 | 1,405 | 67,440 | 340,528 | 341.9 K to 340.5 K (-0.41 %) |
| Apr 18 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 8.49 | 1,405 | 11,928 | 341,933 | 340.5 K to 341.9 K (+0.41 %) |
| Apr 15 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Option Exercise | M | 8.49 | 2,725 | 23,135 | 66,425 | |
| Apr 15 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Sell | S | 48.00 | 2,725 | 130,800 | 340,528 | 343.3 K to 340.5 K (-0.79 %) |
| Apr 15 2016 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President, CEO and ... | Buy | M | 8.49 | 2,725 | 23,135 | 343,253 | 340.5 K to 343.3 K (+0.80 %) |
| Dec 28 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Gift | G | 0.00 | 953 | 0 | 340,303 | 341.3 K to 340.3 K (-0.28 %) |
| Nov 18 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Grant | A | 0.00 | 50,000 | 0 | 341,256 | 291.3 K to 341.3 K (+17.17 %) |
| Oct 26 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Gift | G | 0.00 | 3,337 | 0 | 291,256 | 294.6 K to 291.3 K (-1.13 %) |
| Oct 19 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 27.98 | 4,904 | 137,214 | 294,593 | 299.5 K to 294.6 K (-1.64 %) |
| Oct 19 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 27.36 | 20,096 | 549,827 | 299,497 | 319.6 K to 299.5 K (-6.29 %) |
| Oct 19 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 26.68 | 25,000 | 667,000 | 319,593 | 344.6 K to 319.6 K (-7.25 %) |
| Oct 19 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 27.58 | 22,352 | 616,468 | 344,593 | 366.9 K to 344.6 K (-6.09 %) |
| Sep 23 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 22.06 | 2,648 | 58,422 | 366,945 | 369.6 K to 366.9 K (-0.72 %) |
| Aug 21 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Grant | A | 0.00 | 75,000 | 0 | 369,593 | 294.6 K to 369.6 K (+25.46 %) |
| Aug 19 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Option Exercise | A | 19.25 | 125,000 | 2,406,250 | 125,000 | |
| Jun 24 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 24.77 | 60,822 | 1,506,804 | 294,593 | 355.4 K to 294.6 K (-17.11 %) |
| Jun 24 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Sell | S | 24.23 | 14,178 | 343,575 | 355,415 | 369.6 K to 355.4 K (-3.84 %) |
| May 04 2015 | FPRX | FIVE PRIME THERAPE ... | Williams Lewis T | President and CEO | Grant | A | 0.00 | 13,090 | 0 | 369,593 | 356.5 K to 369.6 K (+3.67 %) |
Page: 1